Free scoping read. A written assessment of your manuscript in two business days, at no cost.

Start one
Contents

On this page

  1. References

Academy · Concepts Definitions

Guidelines for Safe Clinical Research During a Pandemic

The Food and Drug Administration (FDA) is essential in protecting the United States against dangers such as new infectious illnesses, such as the Coronavirus

Pubrica AcademyWritten by the medical writing and biostatistics teamsPublished27 September 2021Reading time2 minutes

The Food and Drug Administration (FDA) is essential in protecting the United States against dangers such as new infectious illnesses, such as the Coronavirus Disease 2019 (COVID-19) pandemic. The FDA is dedicated to providing timely recommendations to assist in the pandemic response. For the length of the COVID-19 public health emergency, the FDA offers this guideline to help sponsors ensure the safety of trial participants, preserve compliance with good clinical practice (GCP), and avoid risks to trial integrity.

  • The unexpected appearance of the COVID-19 pandemic wreaked havoc on the healthcare system, supply chain, economy, and social interactions throughout the world. Clinical research has been suspended or terminated in certain areas due to the pressing demands of patient care. Clinical trials focusing on the treatment and prevention of coronavirus infection were given priority over other research. To improve future preparedness, examine ethical problems in decision-making and competing ethical pressures during the epidemic.
  • Creating and delivering safe and effective diagnostic, therapeutic, and vaccination products are critical to a population’s health, procedures that rely on clinical trials as part of well-organised product development programmes. The clinical research community was unprepared for the disruption created by the COVID-19 pandemic, which has had a global impact on operations and trial conduct. Changes have been made quickly to emphasise patient and participant (as well as healthcare professional) safety and meet the need for social distance to reduce the virus’ transmission. These modifications—clinical trial suspensions, terminations, and continuations—were made after quickly assessing whether risks could be declined and trial and data integrity could be ensured. Examine the ethical issues that arise during pandemic decision-making to improve preparedness and learning. Separate judgments about existing clinical trials from decisions about whether and when to start new studies by analysing required trade-offs.

Need support with this?

Pubrica’s writers, editors and statisticians work with authors on concepts definitions and related publication tasks. The authors keep ownership of the work and responsibility for its content. Talk to the team.

References

  1. Bierer, B. E., et al. “Ethical challenges in clinical research during the COVID-19 pandemic.” Journal of Bioethical Inquiry 17.4 (2020): 717-722.
Get a free quote

Regulations

Check your project against this rule

  1. 1Your work
  2. 2Your details
  3. 3Send
What do you need?

Material you send is held under signed confidentiality, with access limited to the assigned team and encrypted transfer. It is not used to train anything and is not passed to third-party tools. Ask for the agreement before you send anything you would rather cover first.